Back to search
FDAFDA · Food and drugs·Recall number D-1625-2020

Nymalize (nimodipine) oral solution, 60 mg/20 mL, 12 Unit-Dose Cups and 12 Oral Syringes, 2 inner cartons per outer shipping carton, Rx Only, Distributed by arbor Atlanta, GA, NDC 24338-200-12

Published October 7, 2020 · Recall initiated: September 16, 2020

Summary

FDA records drug Class III recall D-1625-2020, published October 7, 2020 and initiated September 16, 2020. Recalling firm: Arbor Pharmaceuticals Inc.; Status: Terminated; Reported quantity: 1846 cartons; Lot: Lot #: 356884 Exp. 11/30/2021. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Subpotent Drug

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Arbor Pharmaceuticals Inc.
Distributor
Nationwide within the United States
Lot
Lot #: 356884 Exp. 11/30/2021
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Nymalize (nimodipine) oral solution, 60 mg/20 mL, 12 Unit-Dose Cups and 12 Oral Syringes, 2 inner cartons per outer shipping carton, Rx Only, Distributed by arbor Atlanta, GA, NDC 24338-200-12 recalled?

Yes. FDA published recall D-1625-2020 on October 7, 2020. Reported hazard: Subpotent Drug

What should I do if I have this product?

Voluntary: Firm initiated · Letter